Handelsbanken Fonder’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $256M | Sell |
2,380,413
-281,890
| -11% | -$30.3M | 0.91% | 12 |
|
2025
Q1 | $269M | Buy |
2,662,303
+106,847
| +4% | +$10.8M | 1.11% | 13 |
|
2024
Q4 | $228M | Buy |
2,555,456
+184,049
| +8% | +$16.4M | 0.87% | 14 |
|
2024
Q3 | $199M | Buy |
2,371,407
+965,080
| +69% | +$80.9M | 0.79% | 17 |
|
2024
Q2 | $108M | Buy |
1,406,327
+190,584
| +16% | +$14.7M | 0.47% | 35 |
|
2024
Q1 | $83.3M | Buy |
1,215,743
+630,905
| +108% | +$43.2M | 0.36% | 55 |
|
2023
Q4 | $33.8M | Buy |
584,838
+36,042
| +7% | +$2.08M | 0.16% | 144 |
|
2023
Q3 | $29M | Buy |
548,796
+4,862
| +0.9% | +$257K | 0.16% | 144 |
|
2023
Q2 | $29.4M | Buy |
543,934
+39,425
| +8% | +$2.13M | 0.16% | 156 |
|
2023
Q1 | $25.2M | Buy |
504,509
+15,412
| +3% | +$771K | 0.15% | 168 |
|
2022
Q4 | $22.6M | Buy |
489,097
+64,158
| +15% | +$2.97M | 0.14% | 176 |
|
2022
Q3 | $16.5M | Buy |
424,939
+3,641
| +0.9% | +$141K | 0.11% | 201 |
|
2022
Q2 | $15.7M | Buy |
421,298
+26,893
| +7% | +$1M | 0.1% | 208 |
|
2022
Q1 | $17.5M | Sell |
394,405
-12,305
| -3% | -$545K | 0.1% | 212 |
|
2021
Q4 | $17.3M | Sell |
406,710
-7,649
| -2% | -$325K | 0.09% | 231 |
|
2021
Q3 | $18M | Buy |
414,359
+12,738
| +3% | +$553K | 0.09% | 221 |
|
2021
Q2 | $17.2M | Buy |
401,621
+45,735
| +13% | +$1.96M | 0.09% | 236 |
|
2021
Q1 | $13.8M | Buy |
355,886
+12,108
| +4% | +$468K | 0.08% | 242 |
|
2020
Q4 | $12.4M | Buy |
343,778
+3,534
| +1% | +$127K | 0.08% | 250 |
|
2020
Q3 | $13M | Buy |
340,244
+28,918
| +9% | +$1.1M | 0.1% | 210 |
|
2020
Q2 | $10.9M | Buy |
+311,326
| New | +$10.9M | 0.09% | 213 |
|
2016
Q1 | – | Sell |
-125,060
| Closed | -$2.31M | – | 275 |
|
2015
Q4 | $2.31M | Buy |
+125,060
| New | +$2.31M | 0.04% | 317 |
|